# Tylosin Antibiotic Diarrhea Dose: Antibiotic-Responsive Diarrhea Dose ## Key Takeaways - The evidence-based starting dose for tylosin-responsive diarrhea (TRD) in dogs is 5 mg/kg orally once daily for seven days, demonstrating 100% control of relapse in a clinical trial, with no significant difference in efficacy compared to higher doses. - TRD is a clinical diagnosis characterized by chronic diarrhea that resolves with tylosin and recurs upon discontinuation, often linked to alterations in the intestinal microbiome and low-grade inflammation rather than classic infection. - A thorough diagnostic workup is crucial to differentiate TRD from other causes of chronic diarrhea, including food-responsive diarrhea, inflammatory bowel disease, exocrine pancreatic insufficiency, and infectious agents, often involving fecal examination, bloodwork (including folate/cobalamin), and potentially imaging or biopsy. - The 5 mg/kg dose is a treatment dose for active diarrhea relapse in dogs previously diagnosed with TRD, not a maintenance dose, and its efficacy is supported by studies showing no significant difference in fecal consistency scores compared to higher doses. - Owners should not self-dose tylosin; veterinary consultation is required for diagnosis, weight-based dosing, and to rule out red flags such as blood in stool, vomiting, or lethargy, which necessitate immediate veterinary care. --- ## Direct Answer and Owner Triage Summary For dogs with suspected tylosin-responsive diarrhea (TRD), a form of antibiotic-responsive diarrhea (ARD), the evidence-based starting dose is **5 mg/kg orally once daily for seven days**. This low-dose regimen was shown to control diarrhea relapse in 100% of dogs in a prospective clinical trial, with no significant difference in efficacy compared to higher doses of 15 mg/kg or 25 mg/kg [1]. The traditional empirical dose of 25 mg/kg once daily remains effective, but the lower dose reduces cost and potential for adverse effects [1][2]. **Owner triage summary:** If your [dog](/knowledge/veterinary-medicine/clinical-methods/dog) has recurrent, non-bloody diarrhea that has previously responded to tylosin, contact your veterinarian before restarting medication. Do not self-dose. The typical course is a seven-day treatment at a weight-based dose. If diarrhea does not improve within 48 hours, if blood appears in the stool, or if your dog becomes lethargic or vomits, stop treatment and seek immediate veterinary care. This article is educational and is not a substitute for veterinary diagnosis or treatment. ## At a Glance: Tylosin Dose Comparison for Canine Diarrhea | Parameter | Low-Dose Protocol | Standard Empirical Protocol | High-Dose Protocol | |------|----------|---------------|----------| | **Dose** | 5 mg/kg PO q24h | 25 mg/kg PO q24h | 15 mg/kg PO q24h | | **Duration** | 7 days | 7 days | 7 days | | **Response Rate (TRD relapse)** | 8/8 dogs (100%) [1] | 14/15 dogs (93%) [1] | 6/7 dogs (86%) [1] | | **Fecal Consistency Score Difference** | No significant difference vs 25 mg/kg (P=0.672) [1] | Reference standard | No significant difference vs 25 mg/kg (P=0.345) [1] | | **Best For** | First-line treatment, cost reduction, minimizing antibiotic exposure | Dogs with previous response to this dose | Alternative when 5 mg/kg is ineffective | | **Evidence Level** | Prospective, single-blinded clinical trial [1] | Placebo-controlled, double-blinded trial [2] | Prospective, single-blinded clinical trial [1] | **Key clinical pearl:** The 5 mg/kg dose is not merely a maintenance dose. It is a treatment dose for active diarrhea relapse in dogs previously diagnosed with TRD [1]. ## Understanding Antibiotic-Responsive Diarrhea (ARD) and Tylosin-Responsive Diarrhea (TRD) Antibiotic-responsive diarrhea is a clinical diagnosis in dogs with chronic diarrhea that resolves with antimicrobial therapy and relapses when therapy is withdrawn. Tylosin-responsive diarrhea is a specific subset of ARD where the macrolide antibiotic tylosin produces a rapid clinical response [2]. The term TRD is used when diarrhea responds to tylosin within a few days, stools remain normal during treatment, and diarrhea recurs within weeks after discontinuation [2]. The pathophysiology of TRD is not fully understood. It is not a classic infectious diarrhea in most cases. The working hypothesis involves alterations in the intestinal microbiome, low-grade inflammation, and possible bile acid malabsorption. Tylosin, a macrolide antibiotic, has both antibacterial and anti-inflammatory properties. It reduces bacterial populations in the small intestine and may modulate the local immune response. The rapid response to tylosin, often within 24 to 48 hours, suggests a direct effect on bacterial populations or metabolic pathways rather than resolution of structural intestinal disease [2]. ### Distinguishing TRD from Other Chronic Enteropathies Chronic diarrhea in dogs has multiple causes. The differential diagnosis includes: - **Food-responsive diarrhea (FRD):** Responds to dietary change alone. - **Immunosuppressive-responsive diarrhea (IRD):** Requires corticosteroids or other immunosuppressants. - **Tylosin-responsive diarrhea (TRD):** Responds to tylosin. - **Inflammatory bowel disease (IBD):** Histologic inflammation, often requires combination therapy. - **Exocrine pancreatic insufficiency (EPI):** Maldigestion, responds to enzyme replacement. - **Infectious causes:** Giardia, Tritrichomonas, Salmonella, Clostridium perfringens. - **Neoplasia:** Intestinal lymphoma or adenocarcinoma. The distinction is often made empirically. A dog with chronic diarrhea that has failed dietary trials but responds to tylosin within days is classified as having TRD [2]. This is a diagnosis of exclusion, and a complete diagnostic workup is recommended before committing to long-term tylosin therapy. ## Risk Factors and Epidemiology TRD is most commonly reported in dogs, though tylosin is also used in other species. In the clinical trial by Kilpinen et al. (2011), 71 client-owned dogs with a history of recurrent diarrhea and prior response to tylosin were enrolled [2]. No specific breed or age predilection was identified, but the condition appears more common in young to middle-aged dogs. Risk factors for developing TRD include: - Previous episodes of acute gastroenteritis. - Dietary indiscretion. - Stress or kenneling. - Concurrent exocrine pancreatic insufficiency. - History of antibiotic use. In pigs, a similar condition, proliferative enteropathy caused by *[Lawsonia intracellularis](/knowledge/bacteria/livestock-bacteria/lawsonia-intracellularis)*, responds to tylosin phosphate. McOrist et al. (1997) demonstrated that oral tylosin phosphate at 100 ppm or 40 ppm in feed prevented clinical signs and lesions of proliferative enteropathy in challenged pigs [3]. This cross-species efficacy supports the role of tylosin in managing bacterial-associated diarrhea, though the canine condition is more complex [3]. ## Veterinary Examination and Diagnostic Approach A definitive diagnosis of TRD requires a thorough workup to rule out other causes of chronic diarrhea. The diagnostic approach includes: ### 1. History and Physical Examination The veterinarian will ask about diet, deworming history, vaccination status, travel history, and the pattern of diarrhea. Key questions include: - How long has the diarrhea been present? - Is it small bowel (large volume, infrequent) or large bowel (small volume, frequent, with straining)? - Is there blood or mucus? - Has the dog been on any medication? - Did the diarrhea respond to previous tylosin treatment? Physical examination focuses on body condition, hydration status, abdominal palpation, and rectal examination. ### 2. Fecal Examination - Direct smear and fecal flotation to rule out parasites (Giardia, coccidia, hookworms). - Fecal culture for bacterial pathogens. - PCR panels for infectious agents. ### 3. Bloodwork - Complete blood count (CBC) to assess for inflammation or infection. - Serum biochemistry panel to evaluate liver, kidney, and pancreatic function. - Pancreatic lipase immunoreactivity (PLI) to rule out pancreatitis. - Folate and cobalamin (B12) levels to assess small intestinal bacterial overgrowth (SIBO) or malabsorption. ### 4. Imaging - Abdominal ultrasound to evaluate intestinal wall thickness, lymph nodes, and other organs. - Radiographs to rule out foreign bodies or obstruction. ### 5. Intestinal Biopsy If the diarrhea does not respond to empirical therapy, or if IBD or neoplasia is suspected, endoscopic or full-thickness intestinal biopsies may be recommended. The diagnosis of TRD is often confirmed by a positive response to a tylosin trial. If diarrhea resolves within 3 to 5 days of starting tylosin and recurs after stopping, TRD is likely [2]. ## Evidence-Based Management of TRD ### The Historical Dose Problem Before the 2014 study by Kilpinen et al., there was no consensus on the correct tylosin dose for dogs. Textbooks recommended daily doses ranging from 25 to 80 mg/kg, with dosing intervals from once to three times daily [1]. This wide variability led to inconsistent clinical outcomes and increased the risk of adverse effects. ### The Low-Dose Evidence The 2014 study by Kilpinen et al. was a prospective, single-blinded, two-arm parallel, clinical field trial designed to evaluate two low-dose oral tylosin regimens for controlling diarrhea relapse in dogs with TRD [1]. The study included dogs that had previously responded to 25 mg/kg of tylosin once daily for seven days. Key findings: - **All eight dogs (100%) responded to the 5 mg/kg dose.** - **Six of seven dogs (86%) responded to the 15 mg/kg dose.** - **14 of 15 dogs (93%) that responded to 25 mg/kg also responded to the lower doses at relapse.** - **There was no significant difference in mean fecal consistency scores between the 25 mg/kg dose and the 5 mg/kg (P=0.672) or 15 mg/kg (P=0.345) doses.** The authors concluded that a suitable dose of tylosin for treating diarrhea relapse in canine TRD could be as low as 5 mg/kg once daily for seven days [1]. This is a significant finding because it reduces the antibiotic load, lowers cost, and may decrease the risk of antimicrobial resistance. ### The Placebo-Controlled Evidence The 2011 study by Kilpinen et al. was a placebo-controlled, randomized, double-blinded, prospective clinical trial [2]. This study enrolled 71 client-owned dogs with a history of recurrent diarrhea and prior response to tylosin. At the initial examination, dogs had no signs of diarrhea. They were randomly assigned to a tylosin group or a placebo group in a 2:1 ratio. When diarrhea recurred during the two-month follow-up, dogs received either tylosin (25 mg/kg q24h for 7 days) or placebo. The treatment outcome was evaluated using fecal consistency scores. The results confirmed that tylosin was significantly more effective than placebo in controlling diarrhea, providing strong scientific evidence for its use in TRD [2]. ### Practical Dosing Protocol Based on the available evidence, the following protocol is recommended for dogs with suspected TRD: 1. **Initial treatment:** Tylosin at 5 mg/kg orally once daily for seven days [1]. 2. **Re-evaluation:** If diarrhea resolves, continue for the full seven days. If diarrhea persists after 48 hours, contact your veterinarian. 3. **Relapse management:** If diarrhea recurs after discontinuation, repeat the same seven-day course [1]. 4. **Long-term management:** Some dogs require intermittent or continuous tylosin therapy. The lowest effective dose should be used. In the 2014 study, dogs that responded to 5 mg/kg maintained normal fecal consistency during the treatment period [1]. ### Tylosin in Other Species While this article focuses on canine diarrhea, tylosin is also used in other species. In pigs, tylosin phosphate administered orally at 100 ppm or 40 ppm in feed was effective for both prevention and treatment of proliferative enteropathy caused by *Lawsonia intracellularis* [3]. This supports the use of tylosin as a targeted antimicrobial in bacterial enteropathies across species. ## Unsafe Home Remedies and Owner Misconceptions Several misconceptions exist regarding tylosin and diarrhea management: **Misconception 1: "Tylosin is a probiotic."** Tylosin is an antibiotic, not a probiotic. It kills bacteria. It should not be used as a daily supplement. **Misconception 2: "If 5 mg/kg works, 25 mg/kg works better."** The evidence shows no significant difference in efficacy between 5 mg/kg and 25 mg/kg [1]. Higher doses increase the risk of adverse effects and antimicrobial resistance without improving outcomes. **Misconception 3: "Tylosin can be given indefinitely."** Long-term antibiotic use can disrupt the normal gut microbiome and promote resistant bacterial strains. Tylosin should be used for the shortest effective duration [1][2]. **Misconception 4: "Human pharmacy tylosin is the same."** Tylosin is a veterinary antibiotic. Human formulations of similar macrolides (e.g., erythromycin, azithromycin) are not interchangeable. Never give human medication to your dog without veterinary approval. **Unsafe home remedies to avoid:** - Giving tylosin without a veterinary diagnosis. - Using expired or improperly stored tylosin. - Combining tylosin with other antibiotics without veterinary guidance. - Stopping treatment early because diarrhea resolved. - Ignoring red flags such as blood in stool, vomiting, or lethargy. ## Prevention and Long-Term Management Preventing TRD relapse is challenging because the underlying cause is not fully understood. Strategies include: - **Dietary management:** A highly digestible, low-residue diet may reduce intestinal inflammation. Some dogs with TRD also have food sensitivities. - **Probiotics:** While not a substitute for tylosin, probiotics may help maintain a healthy gut microbiome during and after antibiotic treatment. - **Stress reduction:** Minimize environmental stressors that can trigger diarrhea. - **Regular deworming:** Control [intestinal parasites](/knowledge/parasites/pet-parasites/intestinal-parasites-dogs-cats-identification-treatment) that can exacerbate diarrhea. - **Monitoring:** Keep a diary of stool consistency to detect early signs of relapse. For dogs that require frequent tylosin courses, the 5 mg/kg dose is preferred to minimize antibiotic exposure [1]. Some veterinarians may recommend a "pulse" protocol, such as treating for seven days, then stopping, and restarting only if diarrhea recurs. ## Prognosis The prognosis for dogs with TRD is generally excellent. Most dogs respond to tylosin within days, and the condition does not progress to severe systemic illness [2]. However, TRD is a chronic condition. Many dogs experience intermittent episodes of diarrhea throughout their lives and require periodic treatment. The prognosis is less favorable if the diarrhea does not respond to tylosin, as this suggests an alternative diagnosis such as IBD, neoplasia, or EPI. In these cases, further diagnostic testing is essential. ## Limitations and When to Contact a Veterinarian This article provides general information based on published clinical trials. It cannot predict the response of any individual dog. The following limitations apply: - The studies cited involved specific populations of dogs with a history of TRD. Results may not generalize to dogs with other causes of diarrhea [1][2]. - The 5 mg/kg dose was effective in a small study of 15 dogs. Larger studies are needed to confirm these findings [1]. - Breed-specific responses have not been studied. Some breeds may metabolize tylosin differently. - Tylosin is not approved by regulatory agencies (e.g., FDA, EMA) for use in dogs. Its use is extra-label and should be based on veterinary judgment. **Contact your veterinarian immediately if:** - Diarrhea does not improve within 48 hours of starting tylosin. - Diarrhea worsens or becomes bloody. - Your dog vomits, becomes lethargic, or refuses to eat. - Your dog shows signs of abdominal pain (pacing, whining, hunched posture). - Your dog is a puppy, senior, or has a pre-existing medical condition. Do not attempt to dose your dog without a current weight and veterinary guidance. Tylosin is available in different formulations (powder, tablets, liquid), and the concentration varies. Your veterinarian will calculate the correct dose based on your dog's weight and the specific product. ## Clinical Reasoning Behind the 5 mg/kg Dose The movement toward a 5 mg/kg dose of tylosin for canine antibiotic-responsive diarrhea represents a meaningful shift in veterinary therapeutic philosophy. For decades, the empirical dose of 25 mg/kg was the default recommendation, largely inherited from older pharmacokinetic studies and clinical experience rather than rigorous dose-finding trials [1]. The 2014 study by Kilpinen and colleagues challenged this assumption by demonstrating that a five-fold lower dose achieved comparable clinical outcomes [1]. Understanding why this works requires a closer look at how tylosin behaves in the canine gastrointestinal tract. Tylosin is a macrolide antibiotic that is poorly absorbed from the gastrointestinal tract. When administered orally, a substantial proportion of the drug remains within the intestinal lumen, where it exerts its primary antibacterial effect. This means that the concentration of tylosin reaching the colonic and small intestinal bacterial populations is largely determined by the oral dose, but even relatively low doses achieve therapeutic concentrations in the gut lumen. The 5 mg/kg dose appears to be sufficient to suppress the bacterial populations or metabolic pathways that drive tylosin-responsive diarrhea (TRD) without requiring the higher systemic concentrations that the 25 mg/kg dose provides [1]. Another consideration is the anti-inflammatory properties of macrolides. Beyond their antibacterial action, macrolides such as tylosin have been shown to modulate immune responses, including reducing pro-inflammatory cytokine production and altering neutrophil function. These effects are dose-dependent in some contexts, but the gastrointestinal concentrations achieved with 5 mg/kg may be adequate to produce local immunomodulation within the intestinal mucosa. This dual mechanism, antibacterial plus anti-inflammatory, may explain why tylosin produces such rapid clinical responses in dogs with TRD, often within 24 to 48 hours [2]. The clinical significance of the lower dose extends beyond simple efficacy. Antibiotic stewardship is a growing concern in veterinary medicine, and reducing the total antimicrobial load in a patient population is a key strategy for slowing the emergence of resistant bacterial strains. By demonstrating that 5 mg/kg is non-inferior to 25 mg/kg, the 2014 trial provided veterinarians with an evidence-based tool to reduce antibiotic exposure while maintaining treatment success [1]. For owners, the lower dose also translates into reduced medication cost, which can be a meaningful factor for dogs that require repeated or intermittent courses of therapy. ## The Diagnostic Workup in Greater Depth The diagnosis of tylosin-responsive diarrhea is fundamentally a diagnosis of exclusion, and the diagnostic journey can be complex. Owners should understand that a veterinarian may recommend a stepwise approach rather than immediate tylosin administration. This is not due to reluctance to treat, but rather to ensure that more serious conditions are not overlooked. ### The Role of Dietary Trials Before antimicrobial therapy is considered, many veterinarians recommend a strict dietary trial. This typically involves feeding a highly digestible, novel protein or hydrolyzed protein diet exclusively for a period of two to three weeks. During this time, no other food, treats, or flavored medications are permitted. If diarrhea resolves on the elimination diet and recurs when the previous diet is reintroduced, a diagnosis of food-responsive diarrhea is made. This distinction is critical because food-responsive diarrhea does not require antibiotic therapy and is managed with long-term dietary modification. The decision to pursue a dietary trial before a tylosin trial is supported by clinical reasoning. Food-responsive diarrhea is more common than TRD in many referral populations, and dietary management avoids the risks of antimicrobial resistance and microbiome disruption. However, in cases where dietary trials have already failed, or where the clinical history strongly suggests a prior response to tylosin, proceeding directly to a tylosin trial may be appropriate [2]. ### Fecal Testing and Parasite Exclusion Fecal flotation and direct smear examination are essential components of the diagnostic workup. Parasites such as Giardia, Tritrichomonas foetus, and various helminths can cause chronic diarrhea that mimics TRD. Giardia, in particular, can produce intermittent, soft, foul-smelling stool that may appear to respond to antimicrobial therapy, as some antibiotics have incidental activity against this protozoan. However, the treatment of choice for giardiasis is fenbendazole or metronidazole, not tylosin. A negative fecal examination does not completely rule out parasitic disease, as organisms may be shed intermittently, and some veterinarians recommend empirical deworming as part of the initial workup. Polymerase chain reaction (PCR) panels can detect the genetic material of specific pathogens, including Clostridium perfringens, Clostridium difficile, and Campylobacter species. These tests are more sensitive than culture but can yield false positives, as these organisms can be present in the gastrointestinal tract of healthy dogs. The clinical significance of a positive PCR result must be interpreted in the context of the dog's signs and other diagnostic findings. ### Laboratory Evaluation A complete blood count and serum biochemistry panel provide valuable information about systemic health. In dogs with uncomplicated TRD, these tests are typically unremarkable. However, abnormalities such as neutrophilia, hypoalbuminemia, or elevated liver enzymes may suggest inflammatory bowel disease, protein-losing enteropathy, or hepatobiliary disease, all of which require different therapeutic approaches. Serum cobalamin (vitamin B12) and folate concentrations are useful markers of small intestinal function. Low cobalamin with normal or elevated folate suggests small intestinal bacterial overgrowth or distal small intestinal disease. Tylosin-responsive diarrhea has been associated with alterations in the intestinal microbiome, and some dogs with TRD may have concurrent cobalamin deficiency that requires supplementation. Measuring these parameters before initiating tylosin provides a baseline and can guide additional therapy. Pancreatic lipase immunoreactivity (PLI) is recommended to rule out pancreatitis, which can cause diarrhea and abdominal discomfort. Exocrine pancreatic insufficiency (EPI), diagnosed by serum trypsin-like immunoreactivity (TLI), is another important differential. Dogs with EPI often present with chronic diarrhea, weight loss, and coprophagia, and they require pancreatic enzyme replacement rather than antibiotics. Interestingly, some dogs with EPI also have concurrent small intestinal dysbiosis and may benefit from tylosin as adjunctive therapy, but the primary treatment remains enzyme supplementation. ### Imaging and Biopsy Abdominal ultrasound is a non-invasive imaging modality that can assess intestinal wall thickness, layering, and motility, as well as evaluate mesenteric lymph nodes and other abdominal organs. In dogs with TRD, ultrasound findings are often normal or show mild, non-specific changes. Significant thickening of the muscularis layer or loss of normal wall layering raises suspicion for inflammatory bowel disease or neoplasia, prompting further investigation. Intestinal biopsy, obtained via endoscopy or surgery, is the gold standard for diagnosing inflammatory bowel disease and intestinal lymphoma. However, biopsy is invasive, requires anesthesia, and is not routinely recommended for every dog with chronic diarrhea. The decision to biopsy is typically reserved for dogs that fail to respond to empirical therapy, including dietary trials and tylosin, or when imaging or laboratory findings suggest a structural lesion. ## Owner Observation and Preparation for the Veterinary Visit Owners play a crucial role in the diagnostic process. The information they provide during the initial consultation often determines the direction of the workup. Preparing for the veterinary visit can make the consultation more efficient and productive. ### What to Document Before the Appointment A stool diary is one of the most useful tools an owner can bring to a veterinary appointment. For at least three to five days before the visit, record the following for each bowel movement: - Time of day - Volume (approximate) - Consistency (using a scale such as the Purina Fecal Scoring System, where 1 is hard and dry and 7 is watery) - Presence of blood, mucus, or undigested food - Any straining or urgency - Any associated behaviors, such as scooting or excessive licking of the perineum Also document the dog's appetite, water intake, and any episodes of vomiting. Note any recent changes in diet, treats, chews, or environmental stressors. If the dog has been on any medication, including over-the-counter supplements or dewormers, list these with doses and dates. ### Questions to Ask the Veterinarian Owners should feel empowered to ask questions about the proposed diagnostic and therapeutic plan. Useful questions include: - What specific conditions are you trying to rule out with these tests? - If the fecal test is negative, what is the next step? - How long should I wait to see improvement after starting tylosin? - What should I do if the diarrhea returns after the seven-day course? - Are there any dietary changes that should accompany tylosin therapy? - What signs would indicate that I need to bring my dog back immediately? ### Understanding the Tylosin Trial A tylosin trial is a therapeutic diagnostic test. The dog receives tylosin at the prescribed dose for seven days, and the owner monitors fecal consistency daily. A positive response, defined as normalization of stool consistency within three to five days, supports the diagnosis of TRD [2]. If the diarrhea does not improve within 48 hours, the owner should contact the veterinarian, as this suggests either an incorrect diagnosis, an inadequate dose, or a concurrent condition. It is important for owners to understand that a positive response to tylosin does not mean the dog is cured. TRD is a chronic, relapsing condition. Many dogs experience recurrent episodes that require repeated courses of therapy. The goal of treatment is to control clinical signs, not to eliminate the underlying predisposition [1][2]. ## The Microbiome and Antimicrobial Resistance The intestinal microbiome is a complex ecosystem of bacteria, archaea, fungi, and viruses that plays a vital role in host health. Antibiotics, including tylosin, disrupt this ecosystem, and the consequences of that disruption can be both beneficial and harmful. ### How Tylosin Alters the Gut Microbiome In dogs with TRD, the microbiome is likely dysbiotic, with an overgrowth of certain bacterial populations or a loss of beneficial commensals. Tylosin reduces the total bacterial load and may selectively suppress the populations responsible for diarrhea. However, it also affects non-target bacteria, potentially reducing the diversity of the gut ecosystem. The clinical significance of this reduction in diversity is not fully understood, but it may contribute to the relapsing nature of TRD. Some research suggests that the gut microbiome can recover after a course of antibiotics, but recovery may be incomplete, particularly after repeated courses. This has led to interest in adjunctive therapies, such as probiotics and fecal microbiota transplantation, to support microbiome restoration. While these approaches are promising, they are not yet standard of care, and their efficacy in dogs with TRD has not been rigorously evaluated. ### The Threat of Antimicrobial Resistance Antimicrobial resistance is a growing concern in both human and veterinary medicine. The use of any antibiotic, including tylosin, exerts selective pressure on bacterial populations, favoring the survival and proliferation of resistant strains. This is particularly relevant for macrolides, as resistance to one macrolide can confer cross-resistance to others, including erythromycin and azithromycin, which are important in human medicine. The 5 mg/kg dose of tylosin represents a responsible approach to antibiotic stewardship. By using the lowest effective dose for the shortest effective duration, veterinarians can minimize the selective pressure on gut bacteria [1]. Owners should also be counseled to complete the full seven-day course, even if the dog's stool normalizes earlier, to reduce the risk of incomplete bacterial suppression and subsequent relapse. ## Special Populations and Comorbidities While TRD is most commonly diagnosed in otherwise healthy adult dogs, special considerations apply to certain populations. ### Puppies and Senior Dogs Puppies have developing immune systems and immature gut microbiomes. Chronic diarrhea in a puppy should never be assumed to be TRD without a thorough workup, as infectious causes such as parvovirus, coronavirus, and parasitic infections are more common and can be life-threatening. If TRD is suspected in a puppy, the 5 mg/kg dose may be used, but close monitoring is essential, as puppies are more susceptible to dehydration and electrolyte imbalances. Senior dogs are more likely to have concurrent diseases, such as chronic kidney disease, liver disease, or neoplasia, that can cause or contribute to diarrhea. A diagnosis of TRD in a senior dog should be made cautiously, and a lower threshold for advanced diagnostics, including imaging and biopsy, is appropriate. The 5 mg/kg dose is generally safe in senior dogs, but dose adjustment may be necessary if there is significant hepatic or renal impairment, as drug metabolism and excretion may be altered. ### Dogs with Exocrine Pancreatic Insufficiency Exocrine pancreatic insufficiency is a condition in which the pancreas fails to produce sufficient digestive enzymes, leading to maldigestion and chronic diarrhea. The primary treatment is pancreatic enzyme replacement therapy. However, dogs with EPI often have concurrent small intestinal dysbiosis, and tylosin may be used as adjunctive therapy to control bacterial overgrowth. In these cases, the 5 mg/kg dose may be effective, but some dogs require higher doses or longer courses. Close communication between the owner and veterinarian is essential to optimize therapy. ### Dogs with Inflammatory Bowel Disease Inflammatory bowel disease is a chronic inflammatory condition of the gastrointestinal tract that requires immunosuppressive therapy, typically with corticosteroids or other immunomodulators. Some dogs with IBD also have a component of bacterial dysbiosis, and tylosin may be used as an adjunctive treatment. However, tylosin is not a substitute for immunosuppressive therapy in dogs with confirmed IBD. The distinction between TRD and IBD is important, as the treatment approaches differ significantly [2]. ### Cats and Other Species While this article focuses on dogs, tylosin is occasionally used in cats with chronic diarrhea. The evidence base for tylosin in cats is less robust than in dogs, and the optimal dose has not been established. Some veterinarians use a dose of 5 to 10 mg/kg once or twice daily, but this is based on anecdotal experience rather than controlled trials. Cats are more sensitive to the gastrointestinal side effects of macrolides, and owners should monitor for vomiting or decreased appetite. In pigs, tylosin phosphate is used for the prevention and treatment of proliferative enteropathy caused by Lawsonia intracellularis. The study by McOrist and colleagues demonstrated that oral tylosin phosphate at 100 ppm or 40 ppm in feed was effective in preventing clinical signs and lesions of the disease [3]. This cross-species evidence supports the role of tylosin in managing bacterial-associated enteropathies, though the canine condition is more complex and likely involves multiple bacterial species and host factors [3]. ## Adverse Effects and Monitoring Tylosin is generally well tolerated in dogs, but adverse effects can occur. The most commonly reported side effects are gastrointestinal and include nausea, vomiting, decreased appetite, and soft stool. These effects are more common at higher doses, which is another reason to prefer the 5 mg/kg dose [1]. ### Recognizing Adverse Effects Owners should be instructed to monitor their dog for the following signs during tylosin therapy: - Vomiting, especially if it occurs more than once or is projectile - Diarrhea that worsens or becomes bloody - Lethargy or weakness - Loss of appetite lasting more than 24 hours - Signs of abdominal pain, such as pacing, whining, or a hunched posture - Skin reactions, such as hives, facial swelling, or itching If any of these signs occur, the owner should stop the medication and contact their veterinarian immediately. In most cases, adverse effects resolve after discontinuation, but supportive care may be needed in severe cases. ### Drug Interactions Tylosin has the potential to interact with other medications. It is metabolized by the liver and can inhibit certain cytochrome P450 enzymes, potentially increasing the concentrations of concurrently administered drugs. While clinically significant interactions are uncommon in veterinary medicine, owners should always inform their veterinarian of all medications, including supplements and over-the-counter products, that their dog is receiving. ### Monitoring During Long-Term Therapy For dogs that require intermittent or continuous tylosin therapy, periodic monitoring is recommended. This may include: - Fecal examinations to rule out the development of parasitic infections - Bloodwork to assess liver and kidney function - Fecal culture or PCR to monitor for the emergence of resistant bacterial strains The frequency of monitoring depends on the individual dog and the duration of therapy. Dogs that require more than two or three courses of tylosin per year should be re-evaluated to confirm the diagnosis and rule out the development of other conditions. ## The Role of Diet in Managing TRD Diet plays a central role in the management of chronic diarrhea in dogs, and this is true for TRD as well. While tylosin is the primary therapeutic agent, dietary modification can support gut health and reduce the frequency of relapse. ### Highly Digestible Diets Highly digestible diets are formulated to maximize nutrient absorption and minimize the amount of undigested material reaching the colon. These diets typically contain high-quality protein sources, limited fat, and easily digestible carbohydrates. They may also contain added fiber, such as psyllium or beet pulp, to help normalize stool consistency. For dogs with TRD, a highly digestible diet may reduce the substrate available for bacterial fermentation in the colon, potentially decreasing the stimulus for diarrhea. Some veterinarians recommend a prescription gastrointestinal diet during and after tylosin therapy. ### Fiber Supplementation Soluble fiber, such as psyllium or pumpkin, can help absorb excess water in the colon and firm up stool. Insoluble fiber, such as wheat bran, adds bulk and can help with motility. The type and amount of fiber should be tailored to the individual dog, as excessive fiber can worsen diarrhea in some cases. ### Probiotics and Prebiotics Probiotics are live microorganisms that, when administered in adequate amounts, confer a health benefit on the host. Prebiotics are non-digestible food ingredients that stimulate the growth of beneficial bacteria. Both have been studied in dogs with various gastrointestinal conditions, but the evidence for their efficacy in TRD is limited. Some veterinarians recommend probiotics during or after tylosin therapy to help restore the gut microbiome. However, the quality and consistency of probiotic products vary widely, and not all strains are effective. Owners should choose a product that has been specifically studied in dogs and should discuss its use with their veterinarian. ## Prognosis and Long-Term Outlook The prognosis for dogs with TRD is generally excellent. Most dogs respond to tylosin within days, and the condition does not progress to severe systemic illness [2]. However, TRD is a chronic condition, and many dogs experience intermittent episodes of diarrhea throughout their lives. ### Factors Associated with a Good Prognosis - Confirmed response to tylosin within three to five days - Normal appetite and energy level during episodes - No blood in the stool - No significant weight loss - No concurrent systemic disease ### Factors Associated with a Less Favorable Prognosis - Failure to respond to tylosin within 48 hours - Presence of blood in the stool - Vomiting or lethargy - Significant weight loss - Hypoalbuminemia or other laboratory abnormalities - Evidence of inflammatory bowel disease or neoplasia on biopsy For dogs that require frequent tylosin courses, the 5 mg/kg dose is preferred to minimize antibiotic exposure [1]. Some veterinarians may recommend a "pulse" protocol, such as treating for seven days, then stopping, and restarting only if diarrhea recurs. This approach balances the need for symptom control with the goal of minimizing antibiotic use. ## The Importance of Veterinary Oversight Tylosin is a prescription medication, and its use in dogs is extra-label in most countries. This means that the drug has not been specifically approved by regulatory agencies for the treatment of diarrhea in dogs, and its use is based on clinical evidence and veterinary judgment. ### Why Self-Medication Is Dangerous Owners may be tempted to keep a supply of tylosin at home and administer it whenever their dog develops diarrhea. This practice is strongly discouraged for several reasons: - Diarrhea has many causes, and not all will respond to tylosin. - The dose must be calculated based on the dog's current weight, which changes over time. - The concentration of tylosin varies between formulations, and errors in dosing can occur. - Repeated use of antibiotics without veterinary oversight increases the risk of antimicrobial resistance. - Delaying appropriate treatment for a more serious condition can have serious consequences. ### The Veterinary-Prescribed Treatment Plan When a veterinarian prescribes tylosin, they will provide specific instructions for dosing, administration, and duration. They will also schedule a follow-up appointment or telephone consultation to assess the dog's response. This oversight is essential to ensure that the treatment is effective and that any adverse effects are promptly addressed. Owners should never share tylosin with other pets or use it for a different dog, as the dose and indication may differ. They should also store the medication securely, out of reach of children and pets, and dispose of any unused medication properly. ## Conclusion The evidence-based tylosin dose for antibiotic-responsive diarrhea in dogs is 5 mg/kg once daily for seven days. This low-dose regimen is as effective as the traditional 25 mg/kg dose, with a 100% response rate in the key clinical trial [1]. The placebo-controlled study confirms that tylosin is genuinely effective for this condition, not merely a placebo effect [2]. For veterinarians, this represents a shift toward more responsible antibiotic stewardship. For pet owners, it means a safer, more cost-effective treatment for a frustrating chronic condition. Always work with your veterinarian to confirm the diagnosis and establish the correct dose for your dog. ## Frequently Asked Questions ### 1. What is the recommended tylosin dose for diarrhea in dogs? The recommended dose for canine tylosin-responsive diarrhea is 5 mg/kg orally once daily for seven days, based on a 2014 clinical trial showing 100% response rate [1]. ### 2. How quickly does tylosin work for diarrhea in dogs? Tylosin typically improves fecal consistency within 24 to 48 hours in dogs with tylosin-responsive diarrhea, though the full seven-day course should be completed [2]. ### 3. Can I give my dog tylosin without a veterinarian's prescription? No, tylosin is a veterinary prescription medication. A veterinarian must diagnose the condition and determine the appropriate dose and duration for your dog. ### 4. Is tylosin safe for long-term use in dogs? Long-term use is not recommended unless specifically prescribed by a veterinarian. The lowest effective dose for the shortest duration should be used to minimize antibiotic resistance and gut microbiome disruption [1]. ### 5. What are the side effects of tylosin in dogs? Common side effects may include nausea, vomiting, or decreased appetite. Serious side effects are rare but can include allergic reactions. Contact your veterinarian if any adverse effects occur. ### 6. Can tylosin be used for diarrhea in cats? Tylosin is sometimes used in cats for chronic diarrhea, but the evidence base is less robust than in dogs. Always consult a veterinarian for feline dosing, as it differs from canine dosing. ### 7. What is the difference between tylosin-responsive diarrhea and inflammatory bowel disease? TRD responds to tylosin therapy, while IBD typically requires immunosuppressive drugs. A definitive diagnosis of IBD requires intestinal biopsy, whereas TRD is often diagnosed by response to treatment [2]. ### 8. How do I store tylosin medication for my dog? Store tylosin according to the product label, typically in a cool, dry place away from direct sunlight. Keep out of reach of children and pets. Check the expiration date before use. ## Regional Considerations The use of tylosin in dogs is extra-label in most countries, including the United States, Canada, the European Union, and Australia. Regulatory bodies such as the FDA (US), EMA (Europe), and APVMA (Australia) do not specifically approve tylosin for canine diarrhea. Veterinarians in these regions may prescribe it under the "cascade" or "extra-label" rules, which allow the use of veterinary medicines for unapproved indications when no suitable alternative exists. In the United Kingdom and other Commonwealth countries, both "diarrhea" and "diarrhoea" are used in veterinary literature. The clinical approach is identical regardless of spelling. Australian veterinarians may encounter different tick species and regional infectious diseases, but TRD is recognized globally. ## Conclusion The evidence-based tylosin dose for antibiotic-responsive diarrhea in dogs is 5 mg/kg once daily for seven days. This low-dose regimen is as effective as the traditional 25 mg/kg dose, with a 100% response rate in the key clinical trial [1]. The placebo-controlled study confirms that tylosin is genuinely effective for this condition, not merely a placebo effect [2]. For veterinarians, this represents a shift toward more responsible antibiotic stewardship. For pet owners, it means a safer, more cost-effective treatment for a frustrating chronic condition. Always work with your veterinarian to confirm the diagnosis and establish the correct dose for your dog. ## Sources [1] [Efficacy of two low-dose oral tylosin regimens in controlling the relapse of diarrhea in dogs with tylosin-responsive diarrhea: a prospective, single-blinded, two-arm parallel, clinical field trial.](https://pubmed.ncbi.nlm.nih.gov/25096196/) [2] [Effect of tylosin on dogs with suspected tylosin-responsive diarrhea: a placebo-controlled, randomized, double-blinded, prospective clinical trial.](https://pubmed.ncbi.nlm.nih.gov/21489311/) [3] [Oral administration of tylosin phosphate for treatment and prevention of proliferative enteropathy in pigs.](https://pubmed.ncbi.nlm.nih.gov/9028475/)
## Related Clinical & Scientific Guides * [Drontal Plus Dewormer: Broad-Spectrum Dose Guide by Weight](/knowledge/veterinary-medicine/calculators-clinical-tools/drontal-plus-dewormer-broad-spectrum-dose-guide-by-weight) * [Panacur Fenbendazole Dewormer: Dog Fecal Parasite Treatment Schedule](/knowledge/veterinary-medicine/calculators-clinical-tools/panacur-fenbendazole-dewormer-dog-fecal-parasite-treatment-schedule) * [Prednisolone for Cats: Feline Safe Steroid Dose and Autoimmune](/knowledge/veterinary-medicine/calculators-clinical-tools/prednisolone-for-cats-feline-safe-steroid-dose-and-autoimmune)